baber/WOPTO huggingface dataset:
Patent CA-2317560-A1 (CA)
Inventor: POTEGA PATRICK H
IPC: H02J5/00
Filed: 1998-11-17
Abstract: A power supply detects power requirements of an electrical device and configures itself to provide the correct power to the device. By using a connector that isolates the device from its battery, the power supply can provide power to the device, recharge the battery, recharge the battery while at the same time providing power to the device, or provide power to the device while preventing the battery from being recharged. A switch used with the connector creates various circuits and is controllable by the power supply, the electrical device, by signals from the electrical device, or by a third device. The power supply may provide power to a plurality of devices and may be used with other power supplies to form a power grid. A master control unit receives inputs from each of the power supplies and controls the delivery and supply of power being the power supplies.
Patent CA-2318381-A1 (CA)
Title: Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
Inventor: ANDRIEUX JEAN
IPC: C07D333/78
Filed: 1998-12-11
Abstract: The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2)m and (R3)m' are such as defined in the description; n represents an integer such that 0<=n<=3; p represents an integer such as defined in the description; B represents a group (a) or (b). The invention is useful for preparing medicines.
Patent CA-2318512-A1 (CA)
Inventor: SCHERMAN DANIEL
IPC: C12N15/87
Filed: 1999-01-28
Abstract: The invention concerns a novel agent for transferring nucleic acids into cells. Said agent is particularly characterised in that it comprises one or several disulphide bonds sensitive to reducing conditions. The invention also concerns compositions comprising such an agent for transferring in vivo, ex vivo or in vitro nucleic acids of interest into different cell types.
Patent CA-2320744-A1 (CA)
Title: Systeme de pose de tapis de sol
Inventor: SCHULTE AXEL
IPC: A47G27/04
Filed: 1998-11-02
Abstract: L'invention concerne un système de pose de tapis de sol, comprenant un tapis, dont le côté à poils (1) forme la surface utile, et un moyen d'accrochage (7) pouvant être fixé au niveau de la surface (25) du sol. Ce moyen d'accrochage (7) présente des éléments d'accrochage saillants (11) qui viennent s'accrocher dans l'envers (5) du tapis, opposé au côté à poils (1). Selon l'invention, l'envers (5) du tapis est formé par un matériau sans boucle, et le moyen d'accrochage présente un matériau également sans boucle (21), collé sur la surface (25) du sol, ainsi qu'un micro-élément de fermeture adhésive (7) qui possède, sur ses deux côtés, des éléments d'accrochage sous forme de tiges (11) comportant, à leurs extrémités, des parties épaissies (13) qui viennent s'accrocher d'une part dans l'envers sans boucle (5) du tapis et d'autre part dans le matériau sans boucle (21) au niveau de la surface (25) du sol.
Patent CA-2321339-A1 (CA)
Inventor: ITO TAKAO
IPC: F04B53/00
Filed: 2000-09-28
Abstract: In a variable piston pump/motor, input/output shafts are pivotably supported by a housing via a shaft support cylinder formed with a spherical outer surface. The housing is disposed so that it can tilt in one direction, pivoting around hydraulic intake/discharge tubes fixed at a position along lines connecting spherical heads of pistons.
Patent CA-2321938-A1 (CA)
Title: Poly zinc finger proteins with improved linkers
Inventor: PABO CARL O
IPC: C07K19/00
Filed: 1999-03-01
Abstract: The present invention provides methods for making chimeric zinc finger proteins with improved linkers, providing zinc finger proteins with enhanced affinity and specificity.
Patent CA-2325788-A1 (CA)
Title: Methode pour generer un maillage hybride permettant de modeliser une formation heterogene traversee par un ou plusieurs puits
Inventor: BALAVEN SOPHIE
IPC: G06T17/20
Filed: 2000-11-28
Abstract: - Méthode pour générer un maillage hybride permettant de modéliser une formation hétérogène traversée par un ou plusieurs conduits, telle que par exemple une  formation souterraine où l'on a foré un ou plusieurs puits dans le but de former un modèle représentatif par exemple d'écoulements de fluides dans ce milieu en accord avec un schéma numérique défini. - La méthode comporte essentiellement l'association d'un premier maillage structuré pour mailler le milieu hétérogène en respectant ses discontinuités, d'un deuxième  maillage structuré de type radial pour mailler une zone autour de chaque conduit ou puits, ce qui permet de mieux respecter des contraintes particulières liées aux écoulement s dans cette zone, et des maillages non structurés de transition que l'on interpose entre  le premier maillage et chaque deuxième maillage de puits. On combine différents maillag es chacun avec ses propres méthodes de formation, de représentation et d'exploration, des maillages structurés avantageux en ce qu'ils facilitent le contrôle et la compréhensio n des images que l'on forme du gisement et des maillages non structurés plus souples pour  réaliser le maillage des zones complexes. - Applications à des simulateurs de gisements d'hydrocarbures par exemple.</ SDOAB>
Patent CA-2326690-A1 (CA)
Inventor: KHAMAR BAKULESH MAFATLAL
IPC: A61K9/00
Filed: 2000-02-02
Abstract: For treating eye diseases, various kinds of medications are used. They are used in form of topical preparations or in form of systemic preparations to be taken orally or parenterally. Of topical preparations some are for topical use only e.g. framycetin, neomycin, loteprednol ebanoate, etc. However, large majority of topical ophthalmic drugs are for systemic use also, e.g.. Ciprofloxacin, Gentamicin, Timolol, Clonidine, Dexamethasone, Betamethasone, Carbachol, etc. Some of these drugs when used topically are also found to have systemic effects and if they are of serious nature limits the use of that drug, e.g. cardiopulmonary effects of B-blockers like timolol. Dryness of mouth, flush, fever, tachy cardia, urinary retention, convulsion irritability with atropine. Hypertension with phenylephine. Increased salivation, nausea, vomiting, diarrhea, stomach cramps, bronchial secretions, bronchial constriction, asthma, bradycardia, paresthesia with miotics, Hypotension with clonidine. Dry mouth, fatigue and drowsiness with apraclonidine and brimonidine.
Patent CA-2328136-A1 (CA)
Inventor: MAHMOOD UMAR
IPC: C07K7/06
Filed: 1999-05-13
Abstract: An intramolecularly-quenched, near infrared fluorescence probe that emits substantial fluorescence only after interaction with a target tissue (i.e., activation) is disclosed. The probe includes a polymeric backbone and a plurality of near infrared fluorochromes covalently linked to the backbone at fluoresence-quenching interaction-permissive positions separable by enzymatic cleavage at fluorescence activation sites. The probe optionally includes protective chains or fluorochrome spacers, or both. Also disclosed are methods of using the intramolecularly-quenched, near infrared fluorescence probes for in vivo optical imaging.
Patent CA-2328626-A1 (CA)
Title: Method for overmolding sink marks for an automotive component
Inventor: PORTER MARSHALL RAY
IPC: B60R21/04
Filed: 1999-04-12
Abstract: A method, molding device and vehicle component (10) provide for minimized sink marks (30) caused by structural ribs (28) in the molding process. Molten material is injected into a first mold cavity to form a primary vehicle component part (20) having structural ribs (28) on a back side. Typically, sink marks (30) may develop at a front surface of the primary vehicle component part (20), located opposite to the structural ribs (28) on the back side. Molten material is injected into a second molding cavity that is arranged to overmold the front surface (26) of the primary vehicle component part (20) and to cover sink marks (30), if any, in the front surface (26). In this manner, a vehicle component (10) is manufactured with structural ribs (28) and without visible sink marks (30).
Patent CA-2333501-A1 (CA)
Inventor: RAAB SIMON
IPC: G06F21/10
Filed: 2001-02-01
Abstract: An exemplary embodiment of the invention is a method of providing an executable program from an executable program provider to a customer for use in a controller of a three dimensional coordinate measurement system. The method includes receiving a request to create an executable program from a customer and obtaining information related to the executable program. The executable program is developed which guides an operator through a number of measurement steps to be performed with the three dimensional coordinate measuring system. The executable program is delivered to the customer over a network.
Patent CA-2337964-A1 (CA)
Inventor: FINKLESTEIN SETH P
IPC: A61P17/02
Filed: 1999-08-06
Abstract: The present invention features methods for preventing, reducing, or eliminating a neurological deficit caused by an injury to the central nervous system (CNS). The methods can be carried out, for example, by administering a polypeptide in the epidermal growth factor (EGF) family to a patient who has such a deficit.
Patent CA-2339853-A1 (CA)
Inventor: STOKES TY JACKSON
IPC: D02G3/44
Filed: 1998-08-12
Abstract: Improved fibers and yarns comprise propylene polymer and are characterized by a novel crystalline microstructure as determined by small angle X-ray diffraction. In addition, continuous filament yarns comprising filaments of propylene polymer are characterized by improved resilience as determined by compressional recovery tests. The fibers and yarns are useful in textile products.
Patent CA-2343719-A1 (CA)
Title: New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof
Inventor: FU QIANG
IPC: A61K48/00
Filed: 1999-09-06
Abstract: The invention provides a cDNA sequence of a new type II human hepatoma derived growth factor (HDGF2). The protein encoded by such sequence is a homology of type I HDGF. The present invention also relates to peptides encoded by the nucleotide sequences, to uses of these polynucleotides and polypeptides, and to methods for producing the said polynucleotides and polypeptides.
Patent CA-2344893-A1 (CA)
Title: Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders
Inventor: CAVAZZA CLAUDIO
IPC: A23L33/15
Filed: 1999-10-06
Abstract: A pharmaceutical product which comprises admixed or separately packaged (A) L-carnitine or an alkanoyl L-carnitine (e.g.: acetyl L-carnitine or propionyl L-carnitine) and (B) a trihydroxy or tetrahydroxystilbene (e.g.: resveratrol) is useful for the prevention and treatment of pathological forms due to neuronal or cerebral disorders.
Patent CA-2346025-A1 (CA)
Title: Tension clamp and screening apparatus
Inventor: SEYFFERT KENNETH WAYNE
IPC: B07B1/48
Filed: 1999-02-18
Abstract: A clamp (10) is provided for releasably securing a screen (93) to a basket sidewall of a vibratory screening apparatus. A body of the clamp has a front plate (20) for abutment with plate (18) of the vibratory screening apparatus. A first link (30) is pivoted at (22) to the front plate (20) and has a first contact surface. A second link (40) is pivoted at (32) to the first link and has a second contact surface. A swivel is pivoted at (42) to the second link. A bolt (60) is formed with a head (61) that projects beyond the front plate (20) and a tail that projects beyond the swivel (50). The bolt is tightenable in place by an adjusting nut (66) threaded onto the tail end thereof which in an expanded locking state of the clamp can compress spring washers (64) between itself and the swivel (50). The links (30, 40) can be moved from their release state (Fig. 2B) to their locking state (Fig. 1B) with the pivot (32) between the links preferably travelling through an "overcentre" position. Adjustment of the nut (66) with the links in the locking position permits the tension applied to the screen (93) to be adjusted after the screen has been clamped into place. Vibratory screen apparatus in which the above clamps can be used is also described.
Patent CA-2347595-A1 (CA)
Inventor: HOJEIBANE HIKMAT
IPC: A61F2/06
Filed: 2001-05-15
Abstract: In accordance with the present invention, there is provided a stent for insertion into a vessel of a patient. The stent is a tubular member having a  thickness and having front and back open ends and a longitudinal axis extending therebetween. The member has a first smaller diameter for insertion into the  vessel, and a second larger diameter for deployment into the vessel. The tubular member includes a plurality of helically oriented continuous adjacent hoops extendi ng between the front and back ends. The hoops have a plurality of longitudinal struts each having opposing ends and a center therebetween, wherein the ends of the  struts are shaped to form a plurality of loops connecting adjacent struts at the en ds of the struts. The tubular member has end loops and the front and back ends thereof , wherein the end loops at each end are substantially aligned with each other along a plane substantially perpendicular to the longitudinal axis.
Patent CA-2348315-A1 (CA)
Title: Linear actuator
Inventor: PRAMPOLINI SILVANO
IPC: F16H61/32
Filed: 2001-05-24
Abstract: An actuator for engaging and disengaging parts together which, during actuation may incur an obstacle to engagement, the actuator including a mechanism for incurring the obstacle and automatically stopping actuation, a mechanism for removing the obstacle to engagement and for automatically restarting actuation upon removal of the obstacle thereby to achieve engagement.
Patent CA-2348730-A1 (CA)
Inventor: WATANABE TAKUYA
IPC: A61K38/00
Filed: 1999-10-27
Abstract: Rat brain stem vicinity-origin and human fetus-origin G protein-coupled receptor proteins, peptide fragments thereof or salts of the same; nucleic acids encoding the receptor proteins and derivatives thereof, etc. The above G  protein-coupled receptor proteins or nucleic acids encoding the same and the derivatives thereof are usable in determining ligands (agonists) to the above G protein-coupled receptor proteins, as preventives and/or remedies for diseases in association with the dysfunction of the G protein-coupled receptor proteins, as gene diagnostics, in screening compounds capable of altering the expression dose of the above receptor proteins or peptide fragments thereof, etc.
Patent CA-2350754-A1 (CA)
Title: Flame resistant thermostable polycarbonate abs moulding compounds
Inventor: ECKEL THOMAS
IPC: C08K5/523
Filed: 1999-11-04
Abstract: Thermoplastic moulding composition comprising at least 2 components chosen from the group consisting of aromatic poly(ester)carbonates, graft polymers of one or more vinyl monomers on one or more graft bases having a glass transition temperature of < 10°C, thermoplastic vinyl (co)polymer and polyalkylene terephthalate and 0.5 to 20 parts by wt. phosphorus compound of the general formula (I).     (see above formula)
Patent CA-2350819-A1 (CA)
Title: Suspension with height control
Inventor: WHITE DARRIS L
IPC: B60G11/12
Filed: 2001-06-14
Abstract: A rear axle suspension for a highway truck that includes a pair of trailing arms suspended below a frame by a pair of hanger brackets. The hanger brackets define a pivot axis for the trailing arms. A supplemental axle locating member is attached to the axle and includes an extension member that in engageable with a bracket held by the frame. The hanger brackets are laterally compliant and each comprise an inner and outer plate, one of which is bent outwardly to define a gap within which an associated trailing arm is mounted. A moment canceling member extends between the hanger brackets and resists outward bending of the brackets. A height control valve is operated by an operating rod having an axis that passes through, or in close proximity, to the roll center of the vehicle in order to reduce ride height errors.
Patent CA-2351803-A1 (CA)
Title: Embout de distribution comportant deux parties assemblees et un revetement de flocage
Inventor: GUERET JEAN-LOUIS
IPC: B65D83/14
Filed: 2001-06-27
Abstract: Embout pour l'application d'un produit cosmétique ou de soins, caractéri sé par le fait qu'il comprend une première partie (14) assemblée avec une secon de partie (15), l'une des deux parties défroissant au moins partiellement une surface d'application apte à être alimentée en produit par au moins un orifice de l'embout, la deuxième partie comportant un revêtement de flocage s'étendant: - au moins jusqu'à une portion de bord de ladite deuxième partie, cette portion de bord étant sensiblement au contact d'une portion de bord correspondante, non floquée, de la première partie, - et/ou jusqu'à une ligne située sensiblement au contact d'une portion de bo rd correspondante, non floquée, de la première partie, la surface de la deuxièm e partie sur laquelle se raccordent les poils du flocage étant située en retrait de l a surface extérieure de la portion de bord de la première partie.
Patent CA-2358743-A1 (CA)
Inventor: FARQUHAR DONALD S
IPC: G06F21/00
Filed: 2001-10-12
Abstract: The present invention provides a security enclosure having an electronic assembly, such as a cryptographic processor card enclosed within an enclosure, surrounded by a tamper respondent wrap. The enclosure further includes a flexible extension cable which electrically connects the wrap and the assembly. The extension cable includes a plurality of interconnections at a first end to form an electrical connection with the assembly, and a plurality of bonding pads at a second end to form an electrical connection with a plurality of corresponding bonding pads of the wrap.
Patent CA-2359526-A1 (CA)
Title: Security system using modular timers
Inventor: LEV ROBERT G
IPC: G04G15/00
Filed: 2001-10-22
Abstract: Electrical timer modules that interact with one another so as to effect random operation of a plurality of electrical devices, creating the appearance that the devices are not operated automatically.  The timer modules include circuitry that allows them to wake up from a sleep state or mode within a random time interval.  Upon waking form the sleep state or mode, each modular timer initially senses for the presence of a transmitted signal. Upon receipt of a transmitted signal each module returns to its sleep state or mode. If no transmitted signal is received, the first timer module that wakes up transmits a signal to the other modules and activates an electrical device connected thereto.
Patent CA-2364840-A1 (CA)
Title: Method and an arrangement for filling a silo
Inventor: DYROY ARE
IPC: B65G69/04
Filed: 2000-02-25
Abstract: The present invention concerns a method and an arrangement for filling a silo (1) with a fluidisable material. The arrangement comprises means (5, 9) for supplying material to an upper area of the silo and also comprises a central material distributor (10). The material distributor comprises a tank (29) which has an inlet (28) and one or more distributor pipes (26, 26') for distributing material to one or more feed units (11, 11') which convey the material down towards the surface of the material in the silo.
Patent CA-2366471-A1 (CA)
Title: Raman amplifier
Inventor: NAMIKI SHU
IPC: H04B10/291
Filed: 2001-01-11
Abstract: A Raman amplifier using at least three excitation frequencies, wherein, when  excitation wavelengths are divided into groups of excitation wavelengths on a short wavelength side and a long wavelength side with an excitation waveleng th having the widest interval between adjacent wavelengths used as a boundary, a group on the short wavelength side contains at least two excitation wavelengths with almost equal wavelength intervals, and a group on the long wavelength side comprises up to two excitation wavelengths. When a certain excitation wavelength is defined as a first channel and second to n-th channels located from there toward the long wavelength side at about 1THs intervals are defined, excitation lights with wavelengths corresponding to t he first to n-th channels are multiplexed and then further multiplexed with an excitation light having a wavelength at least 2THz away from the n-th channe l toward the long wavelength side, for use as an excitation light source. Excitation lights having wavelengths corresponding to channels other than (n - 1)-th and (n-2)-th channels are multiplexed for use as an excitation light source. Excitation lights having wavelengths corresponding to channels other  than (n-2)-th and (n-3)-th channels are multiplexed for use as an excitation  light source.
Patent CA-2368564-A1 (CA)
Title: Constant velocity universal joint
Inventor: NAKAO SHOUICHI
IPC: F16D3/205
Filed: 2002-01-18
Abstract: A constant velocity universal point includes an inner roller and a trunnion. The inner roller has a chamfered portion formed by an inclined surface inclined at an angle not less than an assembling angle .theta.. The inclined surface extends from a starting point defined by a crossing point of a spherical recess of the inner roller and a short radius r of an elliptic cutout formed on the inner roller.
Patent CA-2369014-A1 (CA)
Title: Hinge assembly and method of attachment for composite panel doors
Inventor: BENNETT TIMOTHY J
IPC: E06B3/70
Filed: 2000-11-07
Abstract: A door (10) having a core (32) made from a composite panel material such as medium density fiberboard or particleboard is provided with a plurality of dowels (36) which are secured, such as by an adhesive, within openings (38) extending into the core (32). The dowels (36) and the openings (38) are positioned in alignment with the screw holes (40) in the hinges (26) which mount the door (10) to a jamb (28) or cabinet. Screws (44) or other fasteners extend through the screw openings (40) in the hinges (26) and are secured within the dowels (36). The dowels (36) permit conventional wood screws (44) to be used to mount the hinges (26) to the door (10) and improve the screw holding capability of the door (10). The dowels (36) also eliminate the need to use edge banding for screw holding purposes and thereby eliminate the problems associated with the joint formed between the edge banding and the core material.
Patent CA-2369071-A1 (CA)
Title: Novel lipoic acid derivatives, their preparation, pharmaceutical use and pharmaceutical compositions cantaining them
Inventor: HARNETT JEREMIAH
IPC: A61P9/00
Filed: 2000-03-31
Abstract: The invention concerns novel lipoic acid derivatives, which have an inhibiting action with respect to NO-synthase enzymes producing nitrogen monoxide NO and/or are agents enabling the regeneration of antioxidants or entities trapping reactive oxygen species (ROS) and intervening in a more general manner in the redox status of thiol groups. The invention also concerns methods for preparing them, pharmaceutical compositions containing them and their use for therapeutic purposes, particularly their use as NO-synthase inhibitors and/or as agents acting more generally in the redox status of thiol groups.
Patent CA-2370630-A1 (CA)
Inventor: CLERC GERARD
IPC: G01N1/28
Filed: 2000-04-13
Abstract: The invention concerns devices for directing cylindrical cores (1) rotating about an axis of revolution (12) said cores having been sampled from a rocky environment or the like which has been subjected, during its formation, to an earth's magnetic field and which consequently has a remanent magnetisation.  The inventive device is essentially characterised in that it comprises a bed (2), a cradle (3) and means for associating the cradle (3) with the bed, means for driving the core (1) in rotation substantially about its axis or revolution (12) relative to the cradle when the latter is located in a first portion (5) of the bed (2) and such that its side wall (9) passes substantially through a measuring point (10), means for measuring the magnetic field prevailing at the measuring point, said measuring means being capable of delivering a measuring signal, and means (11) for processing the measuring signal. The invention is particularly useful for directing cores derived from oilfields.